drugset / Trial / NCT04680910

Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) I

NCT04680910

NaSingle-groupOpen-labelBasic science

Summary

Our hypothesis is that targeted propofol infusion in treatment-resistant depressed patients will induce slow wave activity during sedation and augment subsequent sleep slow wave activity. We will recruit 15 participants for this open label single arm Phase I trial. All participants will undergo two propofol infusions 2-6 days apart, with each infusion maximizing expression of EEG slow waves. To minimize bias, there will be no specific gender or ethnic background consideration for enrollment. This will be a single site investigation at Washington University Medical Center.

Timeline

Start
2021-01-14
Primary completion
2024-07-01
Completion
2025-09-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Propofol Small molecule Intravenous

Indications

No indication recorded.